Topic Healthcare

FDA Selects Eli Lilly, Regeneron for Streamlined Manufacturing Review Initiative. The U.S. Food and Drug Administration (FDA) has enrolled pharmaceutical companies Eli Lilly and Regeneron Pharmaceutic

FDA Selects Eli Lilly, Regeneron for Streamlined Manufacturing Review Initiative

The U.S. Food and Drug Administration (FDA) has enrolled pharmaceutical companies Eli Lilly and Regeneron Pharmaceuticals in its new Pre-Approval Inspection Program, an initiative aimed at accelerating the review process for new manufacturing facilities. This program is poised to significantly reduce the time required for drug production sites to gain regulatory approval, potentially improving drug availability and market efficiency for the healthcare sector.

Hong Kong Health Officials Alert to Early Summer Flu Season Peak. Hong Kong's health authorities have warned that the city may enter its summer flu season earlier than usual, with a peak

Hong Kong Health Officials Alert to Early Summer Flu Season Peak

Hong Kong's health authorities have warned that the city may enter its summer flu season earlier than usual, with a peak anticipated later this month. Dr. Edwin Tsui Lok-kin of the Centre for Health Protection urged unvaccinated residents to receive flu jabs, citing increased influenza activity since May and the absence of a preceding winter flu season.